US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

295.76

-35.4700-10.71%

Pre-market: 299.483.72+1.26%05:07 EDT

Volume:530.48K

Turnover:162.52M

Market Cap:569.19M

PE:- -

High:323.00

Open:322.79

Low:294.70

Close:331.23

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:1.45

T/O Rate:27.56%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ramsay Health Care Announces Retirement of Non-Executive Director

Anlon Healthcare Revises AGM Notice After Exchange Observations on Preferential Share Issue

Health Care up as Biotech Momentum Persists

Vital Healthcare Property Trust Sets Q4 DRP Strike Price at Discount

Health Care Roundup: Market Talk

Jazz wins FDA nod for Ziihera gastric cancer use

Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating

Abbott receives FDA authorization for Libre Duo 10 Day system

HHS plans to add FDA deputy roles for technology, drugs, CNBC says

Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens

Sagimet Reiterated as Buy on De-Risked Acne Program and Clearer Regulatory Path; $29 Price Target Maintained

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

FDA approves Imaavy for warm autoimmune hemolytic anemia

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

Decent Holding Provides Operational Update: Community Healthcare Network Expands to 623 Centers and Over 210,000 Paid Members

Analysts’ Top Healthcare Picks: Dyne Therapeutics (DYN), Universal Health (UHS)

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Endovia launches FDA-backed CannEpil veterinary pain program

Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment

Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":295.76,"timestamp":1787947200000,"preClose":331.23,"halted":0,"volume":530479,"hourTrading":{"tag":"盘前","latestPrice":299.48,"preClose":295.76,"latestTime":"05:07 EDT","volume":441,"amount":130791.94758,"timestamp":1788167261455,"change":3.72,"changeRate":0.012578,"amplitude":0.032015},"delay":0,"changeRate":-0.10708571083537127,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Pre-Mkt","change":-35.47,"latestTime":"08-31 05:18:31 EDT","open":322.785,"high":323,"low":294.7,"amount":162523074.03118002,"amplitude":0.085439,"askPrice":303.97,"askSize":100,"bidPrice":295.44,"bidSize":3,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":295.76,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.0034,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":299.48,"preClose":295.76,"latestTime":"05:07 EDT","volume":441,"amount":130791.94758,"timestamp":1788167261455,"change":3.72,"changeRate":0.012578,"amplitude":0.032015},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":1.445542973311124,"impliedVol":0.9101,"impliedVolPercentile":0.528},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.445542973311124,"shares":1924486,"dividePrice":1.0056,"high":323,"amplitude":0.085439,"preClose":331.23,"low":294.7,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":295.76,"committee":-0.941748,"eps":0,"divideRate":0.0034,"volume":530479,"delay":0,"ttmEps":0,"open":322.785,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":317.2,"twentyDayClose":227.4,"sixtyDayClose":165.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662750780","title":"Ramsay Health Care Announces Retirement of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750780","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662750780?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:38","pubTimestamp":1787697487,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has shared an update. Ramsay Health Care has announced that Non-Executive Director Dr Claudia Süssmuth Dyckerhoff ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-announces-retirement-of-non-executive-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-announces-retirement-of-non-executive-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662980757","title":"Anlon Healthcare Revises AGM Notice After Exchange Observations on Preferential Share Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2662980757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662980757?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:33","pubTimestamp":1787693622,"startTime":"0","endTime":"0","summary":"Anlon Healthcare Limited ( ($IN:AHCL) ) has provided an update. Anlon Healthcare Limited has issued a corrigendum to its notice for the 13th Annual...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anlon-healthcare-revises-agm-notice-after-exchange-observations-on-preferential-share-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anlon-healthcare-revises-agm-notice-after-exchange-observations-on-preferential-share-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","LU0128526141.USD","BK4229","BK4195","LU0029874061.USD","BK4588","LABU","XLV","AGM","HCSG","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662527027","title":"Health Care up as Biotech Momentum Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=2662527027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662527027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:04","pubTimestamp":1787691840,"startTime":"0","endTime":"0","summary":"Health-care companies rose as the biotech sub-sector gathered momentum.Moderna shares rose by more than 9%, and were headed for their largest monthly gain on record, due to enthusiasm about its cancer vaccine.Jazz Pharmaceuticals shares rose after the Food and Drug Administration approved the drug maker's product candidate, Ziihera, to treat a form of stomach cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752227","title":"Vital Healthcare Property Trust Sets Q4 DRP Strike Price at Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752227?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:54","pubTimestamp":1787691265,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) just unveiled an update. Vital Healthcare Property Trust has set the strike price for its distribution rein...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-sets-q4-drp-strike-price-at-discount?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-sets-q4-drp-strike-price-at-discount?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK8059","XLV","BK8073","BK4581","VHP.NZ","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662127752","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662127752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662127752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:50","pubTimestamp":1787691000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1259 ET - Moderna's finding that the mRNA-based vaccine it made ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XLV","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662963752","title":"Jazz wins FDA nod for Ziihera gastric cancer use","url":"https://stock-news.laohu8.com/highlight/detail?id=2662963752","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662963752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:30","pubTimestamp":1787689820,"startTime":"0","endTime":"0","summary":"The latest update is out from Jazz Pharmaceuticals ( ($JAZZ) ). On August 25, 2026, Jazz Pharmaceuticals said the U.S. Food and Drug Administration...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jazz-wins-fda-nod-for-ziihera-gastric-cancer-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jazz-wins-fda-nod-for-ziihera-gastric-cancer-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754039","title":"Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754039","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754039?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:15","pubTimestamp":1787688918,"startTime":"0","endTime":"0","summary":"Molecular Partners, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Zhu from LifeSci Capital maintaine...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/molecular-partners-pipeline-momentum-and-early-safety-data-support-unchanged-12-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/molecular-partners-pipeline-momentum-and-early-safety-data-support-unchanged-12-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751483","title":"Abbott receives FDA authorization for Libre Duo 10 Day system","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751483","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662751483?lang=en_us&edition=fundamental","pubTime":"2026-08-26 02:55","pubTimestamp":1787684112,"startTime":"0","endTime":"0","summary":"Abbott (ABT) announced U.S. Food and Drug Administration authorization of its Libre Duo 10 Day system, the world’s first dual glucose-ketone sensin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbott-receives-fda-authorization-for-libre-duo-10-day-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbott-receives-fda-authorization-for-libre-duo-10-day-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABT","IE00BJT1NW94.SGD","LU0882574055.USD","BK4533","LU0320765489.SGD","LU0289739699.SGD","BK4585","SG9999002232.USD","IE00B4R5TH58.HKD","SGXZ23171101.USD","IE0009355771.USD","LU1023059063.AUD","LU0114720955.EUR","LU2133065610.SGD","LU2324357040.USD","LU0432979614.USD","LU1989763427.SGD","LU2468319806.SGD","LABU","LU0266013472.USD","BK4504","SG9999004303.SGD","LU2211815571.USD","LU0868494617.USD","BK4581","LU1721429402.USD","IE00BJJMRZ35.SGD","BK4566","LU1721429741.USD","IE00B2B36J28.USD","PJP","LU0234572021.USD","SGXZ41872573.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1691799644.USD","IE0002141913.USD","LU0122379950.USD","IHI","LU0208291251.USD","LU2237957902.USD","LU1989763690.USD","BK4588","LU2089984988.USD","LU1914381329.SGD","BK4568","LU0211331839.USD","TMED","LU0170899867.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759696","title":"HHS plans to add FDA deputy roles for technology, drugs, CNBC says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 01:20","pubTimestamp":1787678453,"startTime":"0","endTime":"0","summary":"The Department of Health and Human Services is planning to create two new deputy commissioner roles at the Food and Drug Administration, one of whi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hhs-plans-to-add-fda-deputy-roles-for-technology-drugs-cnbc-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hhs-plans-to-add-fda-deputy-roles-for-technology-drugs-cnbc-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4009","LABU","BK4588","HHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756993","title":"Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756993","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756993?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:05","pubTimestamp":1787673903,"startTime":"0","endTime":"0","summary":"The latest update is out from Zymeworks ( ($ZYME) ). Zymeworks Inc. reported that its partner Jazz Pharmaceuticals has secured U.S. Food and Drug A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zymeworks-gains-250-million-milestone-as-jazz-wins-fda-nod-for-her2-cancer-regimens?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zymeworks-gains-250-million-milestone-as-jazz-wins-fda-nod-for-her2-cancer-regimens?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662753708","title":"Sagimet Reiterated as Buy on De-Risked Acne Program and Clearer Regulatory Path; $29 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2662753708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662753708?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669128,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Brandon Folkes from H.C. Wa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sagimet-reiterated-as-buy-on-de-risked-acne-program-and-clearer-regulatory-path-29-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sagimet-reiterated-as-buy-on-de-risked-acne-program-and-clearer-regulatory-path-29-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LABU","BK4139","SGMT","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530687","title":"BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530687","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530687?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669120,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the U.S. FDA has approved the supplemental Biologics License Application for TEVIMBRA in combination with ZIIH...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","TBXU","MRNY","BMED","IBB","BBP","GNMX","GDOC","FRTY","LABU","MEDI","PINK","SYNB","BK4139","IEIH","BK4526","RSPH","PSCH","MRNX","ONC","IDNA","XLVX","LFSC","NVIB","TECB","IYH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662753010","title":"FDA approves Imaavy for warm autoimmune hemolytic anemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662753010","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662753010?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:40","pubTimestamp":1787668811,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration announced it has approved Imaavy injection for warm autoimmune hemolytic anemia in adult and pediatric patien...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-imaavy-for-warm-autoimmune-hemolytic-anemia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-imaavy-for-warm-autoimmune-hemolytic-anemia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175807","title":"U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175807","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175807?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:23","pubTimestamp":1787667780,"startTime":"0","endTime":"0","summary":"Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, providing a new treatment option in front-li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350636/0/en/u-s-fda-approves-ziihera-zanidatamab-hrii-with-and-without-tislelizumab-plus-chemotherapy-in-first-line-her2-advanced-gastroesophageal-adenocarcinoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTF","SBIT","BPI","BMED","CBTA","YBTC","MNRS","BCCC","BTCO","CBTO","BFJL","BITX","BTCL","GDOC","IBIT","BITU","LABU","BTRN","CBOY","BTC","CBXJ","EZBC","MAXI","CBOJ","CBOA","AEIS","DEFI","CBXO","BTCC","BFAP","XBTY","CBTJ","BTCW","BITI","BITY","BITB","ARKB","BRRR","GBTC","BITO","CRC","IDNA","CBTY","NVIB","HODL","FBTC","BTCI","CBXY","DFII","BTCZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662580757","title":"Decent Holding Provides Operational Update: Community Healthcare Network Expands to 623 Centers and Over 210,000 Paid Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2662580757","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662580757?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:30","pubTimestamp":1787664600,"startTime":"0","endTime":"0","summary":"YANTAI, China, Aug.  25, 2026 (GLOBE NEWSWIRE) -- Decent Holding Inc. (NASDAQ: DXST) (“Decent” or the “Company”), a technology-driven provider of wastewater treatment and community-based senior health","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350564/0/en/decent-holding-provides-operational-update-community-healthcare-network-expands-to-623-centers-and-over-210-000-paid-members.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXST","CN","BK4588","BK4120","XBI","CHCT","VHT","BK4550","IXJ","LABU","KBWY","BK4203","XLV","TCAF","NOBL","CGCV","BK4581","BK4585","BK4225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737038","title":"Analysts’ Top Healthcare Picks: Dyne Therapeutics (DYN), Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737038?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:20","pubTimestamp":1787664011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dyne Therapeutics (DYN) and Universal Health (UHS) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dyne-therapeutics-dyn-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dyne-therapeutics-dyn-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","UHS","BK4585","HCSG","BK4588","BK4185","LU0029874061.USD","XBI","LABU","LU0128526141.USD","BK4581","BK4137","DYN","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662423737","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662423737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662423737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:15","pubTimestamp":1787663703,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  slightly advancing and the iShares Biotechnology ETF  up 0.2%.Immatics  shares were up more than 13% after the company said it has agreed to sell about 12.9 million ordinary shares at $8.69 each, and in lieu of ordinary shares to certain investors, pre-funded warrants to buy up to approximately 4.3 million ordinary shares at $8.689 per pre-funded warrant.Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to statements from Veeva. Shares of Veeva Systems were down 0.1% premarket.Bausch + Lomb  stock was up more than 1% after the company said it plans to advance two of its pharmaceutical pipeline assets to new trials based on latest clinical results.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0053666078.USD","LU0823434740.USD","LU0109394709.USD","XBI","BK4504","BK4528","IBB","LU0882574055.USD","LU0114720955.EUR","LU2362541273.HKD","LU0289739699.SGD","BK4581","LU0234570918.USD","BMED","LU1974910355.USD","LU0320765992.SGD","BK4533","IBBQ","XLV","BK4198","BBH","IMTX","LU2362540622.SGD","LU0128526141.USD","TBXU","BLCO","BIIB","BK4139","VEEV","LU2468319806.SGD","LU2089984988.USD","LU0029874061.USD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2237438978.USD","PBE","BK4588","BK4532","REGN","LU2023250504.SGD","LU0058720904.USD","LU0170899867.USD","BK4534","HCSG","LU1917777945.USD","BK4613","LGHT","EKG","IE00B894F039.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737537","title":"Endovia launches FDA-backed CannEpil veterinary pain program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737537?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:58","pubTimestamp":1787662704,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences Inc ( ($EDVA) ) just unveiled an update. On August 25, 2026, Endovia Health Sciences announced that the U.S. Food and Drug ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/endovia-launches-fda-backed-cannepil-veterinary-pain-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/endovia-launches-fda-backed-cannepil-veterinary-pain-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732058","title":"Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732058?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:55","pubTimestamp":1787662500,"startTime":"0","endTime":"0","summary":"President & CEO, Sabrina Martucci Johnson, discusses the Company's shift to commercial stage, upcoming revenue opportunities, Ovaprene's positive interim Phase 3 results and what could drive value ove","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK4099","NVIB","BK4584","BK4007","BK4555","DARE","03160","GDOC","HYLG","IDNA","LABU","BK4585","BK4604","BK4588","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662433737","title":"Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X","url":"https://stock-news.laohu8.com/highlight/detail?id=2662433737","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662433737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:46","pubTimestamp":1787661960,"startTime":"0","endTime":"0","summary":"First patient dosing represents another major clinical milestone for IHL-42X, building on positive Phase 2 RePOSA results demonstrating reductions in AHI of up to 83% and FDA Fast Track designationNEW","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350465/0/en/incannex-announces-first-patient-dosed-in-dreamzz-phase-2-study-of-ihl-42x.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":8,"totalSize":404,"code":"91000000","status":"200"}]}}